Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inthera Bioscience

Inthera Bioscience
2013 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$11.2M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of first-in-class targeted small molecule therapies designed to provide treatment for solid tumors. The company's drug discovery programs are focused on the development of novel first-in-class oral agents blocking aberrant cell signaling in solid tumors and uses proprietary technology platform to rationally design protein-protein interaction inhibitors, enabling patient to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Einsiedlerstrasse 34
  • 8820 Waedenswil
  • Switzerland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inthera Bioscience’s full profile, request a free trial.

Inthera Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 26-Jun-2018 $11.2M 000.00 Completed Pre-Clinical Trials
1. Seed Round 14-Dec-2015 00.000 00.000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Inthera Bioscience Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Aglaia Biomedical Ventures Venture Capital Minority 000 0000 000000 0
Eva Capital Accelerator/Incubator Minority 000 0000 000000 0
M Ventures Corporate Venture Capital Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0

Inthera Bioscience Executive Team (5)

Name Title Board
Seat
Contact
Info
Ulrich Kessler Co-Founder & Chief Executive Officer
Monique Schiersing Huser Chief Operating Officer
Bernd Hentsch Ph.D Chief Development Officer
Ralph Lindemann Ph.D Chief Scientific Officer
Paramjit Arora Co-Founder

Inthera Bioscience Board Members (8)

Name Representing Role Since Contact
Info
Anker Lundemose Ph.D Inthera Bioscience Board Member 000 0000
Emmanuelle Coutanceau Ph.D Novo Holdings Board Member 000 0000
Jasper Bos Ph.D M Ventures Board Member 000 0000
Keno Gutierrez Ph.D M Ventures Board Member 000 0000
Klaus Schollmeier Ph.D Self Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »